Incyte Corp. (INCY)
122.91
+5.32
(+4.52%)
USD |
NASDAQ |
Nov 04, 16:00
123.00
+0.09
(+0.07%)
After-Hours: 17:15
Incyte Total Return Price : 122.91 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 117.59 |
| November 02, 2026 | 120.04 |
| October 30, 2026 | 120.39 |
| October 29, 2026 | 116.80 |
| October 28, 2026 | 116.87 |
| October 27, 2026 | 116.60 |
| October 26, 2026 | 113.31 |
| October 23, 2026 | 115.71 |
| October 22, 2026 | 116.93 |
| October 21, 2026 | 113.44 |
| October 20, 2026 | 116.62 |
| October 19, 2026 | 113.25 |
| October 16, 2026 | 113.07 |
| October 15, 2026 | 113.27 |
| October 14, 2026 | 111.57 |
| October 13, 2026 | 108.62 |
| October 12, 2026 | 111.36 |
| October 09, 2026 | 112.79 |
| October 08, 2026 | 112.75 |
| October 07, 2026 | 113.44 |
| October 06, 2026 | 112.73 |
| October 05, 2026 | 114.13 |
| October 02, 2026 | 115.30 |
| October 01, 2026 | 117.14 |
| September 30, 2026 | 121.35 |
| Date | Value |
|---|---|
| September 29, 2026 | 123.20 |
| September 28, 2026 | 124.82 |
| September 25, 2026 | 123.89 |
| September 24, 2026 | 124.44 |
| September 23, 2026 | 124.64 |
| September 22, 2026 | 126.93 |
| September 21, 2026 | 124.65 |
| September 18, 2026 | 125.31 |
| September 17, 2026 | 127.62 |
| September 16, 2026 | 124.75 |
| September 15, 2026 | 121.74 |
| September 14, 2026 | 122.19 |
| September 11, 2026 | 121.47 |
| September 10, 2026 | 123.28 |
| September 09, 2026 | 126.01 |
| September 08, 2026 | 124.40 |
| September 04, 2026 | 126.75 |
| September 03, 2026 | 128.00 |
| September 02, 2026 | 128.83 |
| September 01, 2026 | 125.01 |
| August 31, 2026 | 123.22 |
| August 28, 2026 | 124.37 |
| August 27, 2026 | 127.74 |
| August 26, 2026 | 128.12 |
| August 25, 2026 | 129.72 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 930.74 |
| Mirum Pharmaceuticals, Inc. | 97.26 |
| AbbVie, Inc. | 294.77 |
| Alnylam Pharmaceuticals, Inc. | 160.91 |
| Biogen, Inc. | 254.51 |